Director of Nonclinical Safety, Cambridge, MA
Lead the development and execution of nonclinical safety strategies for small molecule and biologic drug candidates in an AI-driven drug discovery environment. Pioneer the integration of artificial intelligence into toxicology assessment, build a scalable safety function, and collaborate across interdisciplinary teams to de-risk clinical translation. Represent the company in regulatory interactions with health authorities and help validate AI-generated safety models for regulatory acceptance.